- Home
- GOSS vs NGS Comparison
GOSS vs NGS Comparison
Compare GOSS & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- NGS
- Stock Information
- Founded
- GOSS 2015
- NGS 1998
- Country
- GOSS United States
- NGS United States
- Employees
- GOSS N/A
- NGS N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- NGS Oilfield Services/Equipment
- Sector
- GOSS Health Care
- NGS Energy
- Exchange
- GOSS Nasdaq
- NGS Nasdaq
- Market Cap
- GOSS 262.5M
- NGS 312.1M
- IPO Year
- GOSS 2019
- NGS 2002
- Fundamental
- Price
- GOSS $1.38
- NGS $24.48
- Analyst Decision
- GOSS Strong Buy
- NGS Strong Buy
- Analyst Count
- GOSS 3
- NGS 2
- Target Price
- GOSS $7.33
- NGS $32.50
- AVG Volume (30 Days)
- GOSS 2.6M
- NGS 76.7K
- Earning Date
- GOSS 08-11-2025
- NGS 08-13-2025
- Dividend Yield
- GOSS N/A
- NGS N/A
- EPS Growth
- GOSS N/A
- NGS 76.16
- EPS
- GOSS N/A
- NGS 1.34
- Revenue
- GOSS $124,590,000.00
- NGS $161,218,000.00
- Revenue This Year
- GOSS N/A
- NGS $13.56
- Revenue Next Year
- GOSS $91.14
- NGS $15.42
- P/E Ratio
- GOSS N/A
- NGS $18.20
- Revenue Growth
- GOSS N/A
- NGS 22.64
- 52 Week Low
- GOSS $0.66
- NGS $16.70
- 52 Week High
- GOSS $1.55
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- GOSS 61.04
- NGS 44.42
- Support Level
- GOSS $1.20
- NGS $24.41
- Resistance Level
- GOSS $1.39
- NGS $25.46
- Average True Range (ATR)
- GOSS 0.09
- NGS 1.02
- MACD
- GOSS 0.00
- NGS -0.32
- Stochastic Oscillator
- GOSS 82.91
- NGS 8.09
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.